1561-1580 of 2019 < first | | | last >
  • Drug Development Through the Looking Glass

    Contract manufacturers and intermediates suppliers are raising the bar for chiral chemistry in pharmaceutical development.

    Angelo De Palma, Ph.D., Contributing Editor
  • PAT in Perspective: Give Credit Where Credit is Due

    PAT and analytical services don’t always mix, as PAT columnist Emil Ciurczak relates. His advice: Don’t allow your PAT group to become a stepchild. Ensure that it receives credit for PAT-based improvements.

    Emil W. Ciurczak, Chief Technical Officer, Cadrai Group
  • Ranbaxy’s Designs on Quality

    Global Quality Chief Ranjit Barshikar discusses the challenge of embracing Quality by Design during a period of intense growth.

  • Tata Consulting, Pavilion and Thermo Electron Link Up for PAT

    Pavilion Technologies recently allied with Tata Consulting Services to implement PAT and advanced process control in the pharmaceutical industry. The alliance builds upon a similar, earlier partnership Pavilion and Thermo Electron.

  • A Wave, Suspended: Follow-on Biologics

    FDA has yet to issue guidance on biosimilars, but scientific advances promise to aid regulators and enable “quality by design.”

    Angelo De Palma, Ph.D., Contributing Editor, and Paul Thomas, Managing Editor
  • With RFID, the System is the System

    RFID’s real benefits are only found in the data and come from good systems design, as prominent case studies illustrate.

    Bert Moore, Director, Communications and Media Relations, AIM Global, and Consultant, IDAT Consulting
  • Lessons from an E-Pedigree Early Adopter

    FFF’s Patrick Schmidt discusses the cutting edge of electronic pedigrees, and shares IT challenges and the benefits of leading rather than lagging.

    Paul Thomas, Managing Editor
  • The State of the E-Pedigree Union

    Keeping up-to-date with shifting legislation is a prerequisite for e-pedigree implementation; RFID is not.

    Brenda Kelly, VP of Marketing and Regulatory Affairs, SupplyScape, Inc.
  • Seals of Approval

    At AstraZeneca’s Westborough facility, the secret to blow-fill-seal success has been developing broad expertise, and seeing implementation and operations challenges as opportunities for growth.

  • Contract Manufacturing Mood is Upbeat: A Report from Informex

    Companies attending the recent Informex custom chemicals exhibition in Orlando, Fla., reported renewed investment in their businesses, albeit in more measured terms than in the earlier heyday of pricey acquisitions and major capacity expansions.

1561-1580 of 2019 < first | | | last >